These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28676139)

  • 1. Object decision and multiple sclerosis: a preliminary study.
    Caputi N; Matrella A; Totaro R; Raparelli C; Pontecorvo S; Di Giacomo D; Passafiume D
    Funct Neurol; 2017; 32(2):69-75. PubMed ID: 28676139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
    Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of decision-making in multiple sclerosis: A neuroeconomic approach.
    Sepúlveda M; Fernández-Diez B; Martínez-Lapiscina EH; Llufriu S; Sola-Valls N; Zubizarreta I; Blanco Y; Saiz A; Levy D; Glimcher P; Villoslada P
    Mult Scler; 2017 Nov; 23(13):1762-1771. PubMed ID: 27903935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timed instrumental activities of daily living in multiple sclerosis: The test of everyday cognitive ability (TECA).
    Charvet LE; Shaw MT; Sherman K; Haas S; Krupp LB
    Mult Scler Relat Disord; 2018 Jul; 23():69-73. PubMed ID: 29778936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
    Cogo MG; Rota S; Fusco ML; Mapelli C; Ferri F; Appollonio IM; Isella V
    J Clin Exp Neuropsychol; 2014; 36(10):1066-75. PubMed ID: 25486588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capacity for financial decision making in multiple sclerosis.
    Tracy VL; Basso MR; Marson DC; Combs DR; Whiteside DM
    J Clin Exp Neuropsychol; 2017 Feb; 39(1):46-57. PubMed ID: 27430343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual object recognition in multiple sclerosis.
    Laatu S; Revonsuo A; Hämäläinen P; Ojanen V; Ruutiainen J
    J Neurol Sci; 2001 Apr; 185(2):77-88. PubMed ID: 11311287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention and memory dysfunctions in mild multiple sclerosis.
    Tinnefeld M; Treitz FH; Haase CG; Wilhelm H; Daum I; Faustmann PM
    Eur Arch Psychiatry Clin Neurosci; 2005 Oct; 255(5):319-26. PubMed ID: 15645161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of cognitive evoked potentials for detecting early cognitive disorders in multiple sclerosis].
    Magnié MN; Bensa C; Laloux L; Bertogliati C; Faure S; Lebrun C
    Rev Neurol (Paris); 2007 Nov; 163(11):1065-74. PubMed ID: 18033045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social Cognition Abilities in Patients With Different Multiple Sclerosis Subtypes.
    Henry A; Tourbah A; Chaunu MP; Bakchine S; Montreuil M
    J Int Neuropsychol Soc; 2017 Sep; 23(8):653-664. PubMed ID: 28656885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment among different clinical courses of multiple sclerosis.
    Brissart H; Morele E; Baumann C; Perf ML; Leininger M; Taillemite L; Dillier C; Pittion S; Spitz E; Debouverie M
    Neurol Res; 2013 Oct; 35(8):867-72. PubMed ID: 23816638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
    Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
    Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired social cognition in multiple sclerosis.
    Pöttgen J; Dziobek I; Reh S; Heesen C; Gold SM
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):523-8. PubMed ID: 23315621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
    PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Italian validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the application of the Cognitive Impairment Index scoring procedure in MS patients.
    Argento O; Incerti CC; Quartuccio ME; Magistrale G; Francia A; Caltagirone C; Pisani V; Nocentini U
    Neurol Sci; 2018 Jul; 39(7):1237-1244. PubMed ID: 29704074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.
    Kizlaitienė R; Kaubrys G; Giedraitienė N; Ramanauskas N; Dementavičienė J
    Med Sci Monit; 2017 Feb; 23():588-597. PubMed ID: 28145395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effects of high-education levels on cognition in different stages of multiple sclerosis.
    Rimkus CM; Avolio IMB; Miotto EC; Pereira SA; Mendes MF; Callegaro D; Leite CDC
    Mult Scler Relat Disord; 2018 May; 22():41-48. PubMed ID: 29554549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive decline of decision-making performances during multiple sclerosis.
    Simioni S; Ruffieux C; Kleeberg J; Bruggimann L; du Pasquier RA; Annoni JM; Schluep M
    J Int Neuropsychol Soc; 2009 Mar; 15(2):291-5. PubMed ID: 19203433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multiple sclerosis, cognitive function, and quality of life.
    Højsgaard Chow H; Schreiber K; Magyari M; Ammitzbøll C; Börnsen L; Romme Christensen J; Ratzer R; Soelberg Sørensen P; Sellebjerg F
    Brain Behav; 2018 Feb; 8(2):e00875. PubMed ID: 29484253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.